This bill allows physician associates to work as the main healthcare providers in clinics that do not have a doctor on staff, removing the current requirement for them to have a formal practice agreement with an active physician. It also changes consultation rules by making it optional for physician associates to consult with physicians and removes the mandate that a physician must be available at all times for consultation. These changes aim to address shortages of medical providers, particularly in rural areas, by increasing the number of physician associates who can practice primary care. The legislation applies to physician associates, healthcare facilities, and medical practices across Maine.
This bill amends Maine's insurance code to explicitly include the MaineCare program as a "carrier" for prescription drug benefit purposes. The change clarifies that MaineCare, which provides health coverage to low-income residents, is treated similarly to private insurance carriers under state insurance regulations. By adding MaineCare to the definition of carrier, the legislation ensures the program falls under existing insurance code provisions governing prescription drug benefits. This adjustment affects how MaineCare is classified within the state's insurance framework without altering the program's core eligibility or funding structure.
LD 2004 modifies Maine's existing Fund To Address Food Insecurity and Provide Nutrition Incentives to better support local programs. It allows the fund to match private/public contributions up to $50,000 annually, prioritizing Maine-based organizations with experience helping low-income residents use federal food assistance (like SNAP) to buy locally grown fruits and vegetables. The bill requires organizations applying for funds to demonstrate how they will leverage the money or have a history of promoting local food access. It also mandates regular reporting and audits to ensure funds are used appropriately for nutrition incentive programs.
LD 697 directs Maine's Prescription Drug Affordability Board to set annual spending targets for prescription drugs purchased by state and local government health plans (excluding MaineCare), using a formula based on a 10-year average of medical care costs plus inflation, minus savings. The board must assess cost-reduction strategies, including reference-based pricing - which aligns drug prices with those in other regions - and establish a 12-member advisory council with representatives from state agencies, labor unions, and consumer groups to advise on setting targets and methods. The board will also identify public payors (state, county, and municipal health plans) likely to exceed the spending targets.
LD 117 provides $1.23 million in state funding for sexual assault services during the 2025-2026 fiscal year, increasing to $1.83 million for 2026-2027. The funds are allocated through the Department of Health and Human Services' Purchased Social Services program to directly support local sexual assault service providers. This funding covers essential services like crisis counseling, medical advocacy, and legal support for survivors. The bill does not create new programs but ensures sustained financial support for existing services across Maine.
LD 82 extends a permanent presumption in Maine's workers' compensation law that automatically considers post-traumatic stress disorder (PTSD) work-related for certain public safety workers. This applies to law enforcement officers, corrections officers, E-9-1-1 dispatchers, firefighters, and emergency medical services personnel diagnosed with PTSD. Currently, this presumption was set to expire on October 1, 2025, but the bill removes that expiration date. As a result, these workers no longer need to prove their PTSD was caused by job duties to qualify for compensation benefits.
LD 1937 requires hospitals and certain hospital-affiliated outpatient providers (like those offering imaging, lab services, cardiac diagnostics, or expensive equipment-based care) to establish and maintain financial assistance programs for eligible patients. These programs must provide charity care consistent with existing rules, based on family income thresholds defined in the bill. Providers who deny access without justification face civil fines up to $10,000 per violation, enforced by the Attorney General or affected patients through court action. The bill repeals an older section (1716) and creates a new section (1716-A) to define charity care requirements and eligibility. It directly affects Maine hospitals and specific outpatient service providers meeting the bill's criteria.
LD 532 expands Maine's assault law to specifically protect all health care workers in hospital emergency rooms. The bill defines assault on these workers as a Class C crime, covering anyone employed or contracted by a state-licensed health care entity (including hospitals and clinics) while performing their job in the emergency room. This change directly affects health care workers in Maine's emergency departments by strengthening legal consequences for assaults against them. The key provision amends existing statute §752-F to broaden the definition beyond previous limitations, ensuring all licensed health care workers in emergency settings receive the same legal protection.
LD 886 regulates medication abortions in Maine by requiring in-person consultations and prescriptions from licensed health care professionals. It prohibits purchasing or obtaining medication abortion drugs online and mandates that providers explain the process, expected experiences, physical/emotional/spiritual risks, and potential reversal options to patients. The bill directly affects individuals seeking medication abortions and the health care professionals who provide them. These provisions aim to standardize access and information for medication abortions under Maine law.
LD 887 requires health care providers to be physically present during chemical abortions, including examining the patient, scheduling a follow-up within 7 days, and providing a labeled catch kit and medical waste bag for proper disposal. It makes manufacturers of abortion drugs liable for the proper disposal of the drugs and cleanup if endocrine disruptors (chemicals interfering with hormones) are found in wastewater, imposing $20,000 civil penalties for violations. The bill directly affects providers prescribing abortion drugs, manufacturers of these drugs, and patients receiving chemical abortions. Exceptions apply only for life-threatening medical emergencies. This bill does not change the legal status of abortion but adds specific procedural and disposal requirements.